Gentas' mission is to bridge BioPharma’s translational gap by providing preclinical testing services using miniature swine models. Gentas will dramatically improve the success rate for testing by 1) improving the predictability of testing from rodents in earlier stages and 2) lowering the total cost of R&D. In short, Gentas will enable customers to leverage the predictive miniature swine platform to deliver large animal model insight at a fraction of the cost and twice the speed.